People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CorriXR Therapeutics, Inc. | — | Biotechnology | Series A | $6.5M | $90.0M | 2022 |
Eric Kmiec at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Kmiec on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Brilliant | 1 | 5 |
| Stella Vnook | 1 | 5 |
| Jeffrey Carper | 1 | 1 |
| Deborah Moorad | 1 | 1 |
| Janice Nevin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.